文献速递神经肿瘤

和肽素在内镜下垂体腺瘤手术患者术后低钠血症和高钠血症预测中的作用

Role of Copeptin in Predicting Postoperative Hyponatremia and Hypernatremia in Patients Undergoing Endoscopic Pituitary Adenoma Surgery.
PubMed 文献 · Neurosurgery · 2024-03-29

这项前瞻性研究纳入50例内镜下垂体腺瘤手术患者,检测术前(C1)、拔管时(C2)和术后第4天(C3)的血清和肽素水平。结果显示,C2较C1相对降低者全部发生短暂性尿崩症(P=0.0002),C2较C1相对升高者88%发生早期低钠血症(P<0.01),C3较C1相对升高者75%发生迟发性低钠血症(P=0.003)。

要点

  • 拔管时和肽素较术前相对降低可预测短暂性中枢性尿崩症。
  • 拔管时和肽素较术前相对升高可预测早期低钠血症。
  • 术后第4天和肽素较术前相对升高可预测迟发性低钠血症。

核心结论

  • 和肽素早期变化(C2-C1)的相对升高或降低可分别预测早期低钠血症或短暂性中枢性尿崩症的发生。
  • 和肽素延迟变化(C3-C1)的相对升高可预测迟发性低钠血症的发生。

研究设计与样本

  • 前瞻性研究,纳入50例接受内镜下垂体腺瘤手术的患者。
  • 检测术前(C1)、拔管时(C2)和术后第4天(C3)的血清和肽素水平,并收集围手术期液体和钠平衡数据。

主要发现

  • 发生短暂性尿崩症的患者100%出现C2较C1相对降低(P=0.0002)。
  • 发生早期低钠血症的患者88%出现C2较C1相对升高(P<0.01)。
  • 发生迟发性低钠血症的患者75%出现C3较C1相对升高(P=0.003)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Arginine vasopressin (AVP) is an important hormone responsible for maintaining sodium homeostasis after pituitary surgery. The measurement of AVP levels is difficult because of its short half-life (t 1/2 ). Copeptin is a preprohormone of AVP, and it is a more stable peptide, which can be used as surrogate marker for AVP. This study aims to assess the role of copeptin as a predictor of postoperative hyponatremia and hypernatremia in patients undergoing endoscopic pituitary adenoma surgery. METHODS: This prospective study included 50 patients who underwent endoscopic pituitary adenoma surgery. Serum copeptin levels of these patients were assessed (1) preoperatively (C1), (2) at extubation (C2), and (3) postoperative day 4 (C3). Perioperative data regarding fluid and sodium balance were collected from patients. Statistical analysis was done using the above data. RESULTS: The copeptin values were assessed against the sodium disturbances. 100% of patients who developed transient diabetes insipidus had a relative decrease in C2 from C1 ( P - .0002). 88% of patients who developed early hyponatremia had a relative increase in C2 as compared with C1 ( P < .01). 75% of patients who developed delayed hyponatremia had a relative increase in C3 as compared with C1 ( P = .003). CONCLUSION: A relative increase or decrease in early change in copeptin (C2-C1) can predict development of early hyponatremia or transient central diabetes insipidus, respectively. A relative increase in delayed change in copeptin (C3-C1) can predict development of delayed hyponatremia.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Binu A, Hv E, Nair P, et al. Role of Copeptin in Predicting Postoperative Hyponatremia and Hypernatremia in Patients Undergoing Endoscopic Pituitary Adenoma Surgery. Neurosurgery. 2024. PMID: 38551356. doi:10.1227/neu.0000000000002927

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。